Vimarsana
Biggest News Aggregation in the World

Manual Injection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Manual Injection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Manual Injection Today - Breaking & Trending Today

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for Anaphylm™ at American College of Allergy Asthma and Immunology (ACAAI) Annual Meeting - Vimarsana News

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for Anaphylm™ at American College of Allergy Asthma and Immunology (ACAAI) Annual Meeting

Published: November 10, 2023

WARREN, N.J., Nov. 10, 2023 -- Aquestive Therapeutics, Inc. , a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and...

Source: marketscreener.com
Related Topics:
United StatesStephanie CarringtonDan BarberCompany Or AquestiveEpinephrine Following AdministrationAmerican College Of Allergy AsthmaExchange CommissionAquestive Therapeutics IncSublingual FilmAmerican CollegeAllergy AsthmaChief ExecutivePoster SectionEpinephrine AdministeredManual InjectionHealthy AdultsPoster SchedulePrivate Securities Litigation Reform ActQuarterly ReportsCurrent ReportsAquestive Therapeutics
Aquestive Therapeutics Reports Positive Results from Latest Clinical Studies Evaluating Pharmacokinetic and Pharmacodynamic Performance of Anaphylm ™ (epinephrine) Sublingual Film and Provides Findings from Recent Auto-Injector Clinical Study - Vimarsana News

Aquestive Therapeutics Reports Positive Results from Latest Clinical Studies Evaluating Pharmacokinetic and Pharmacodynamic Performance of Anaphylm ™ (epinephrine) Sublingual Film and Provides Findings from Recent Auto-Injector Clinical Study

Published: May 31, 2023

Time to maximum blood concentration for Anaphylm was 10 minutes with a range of 5 to 20 minutesEarly drug exposure at 10 minutes for Anaphylm was similar to Auvi-Q® auto-injector 0.3mg and over... | May 31, 2023

Source: marketscreener.com
Related Topics:
United StatesStephanie CarringtonDaniel BarberExchange CommissionAquestive Therapeutics IncBelcher PharmaceuticalsSingle Administration Pilot Pk StudyCompany Or AquestiveProfessor Of Medicine At Johns Hopkins UniversityChief Executive OfficerAssociate ProfessorJohns Hopkins UniversityComparing Different Auto InjectorsManual InjectionRepeat DoseTeva Pharmaceutical United StatesPrivate Securities Litigation Reform ActSublingual FilmAnnual ReportQuarterly ReportsCurrent ReportsCurrent ReportAquestive TherapeuticsNc Stock ExchangePress Release